T. Rowe Price Associates’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $60.8M | Sell |
|
|||||
|
2025
Q2 | $103M | Sell |
|
|||||
|
2025
Q1 | $134M | Sell |
|
|||||
|
2024
Q4 | $325M | Sell |
|
|||||
|
2024
Q3 | $510M | Buy |
|
|||||
|
2024
Q2 | $240M | Sell |
|
|||||
|
2024
Q1 | $217M | Buy |
|
|||||
|
2023
Q4 | $168M | Buy |
|
|||||
|
2023
Q3 | $123M | Buy |
|
|||||
|
2023
Q2 | $109M | Buy |
|
|||||
|
2023
Q1 | $1.2M | Buy |
|
|||||
|
2022
Q4 | $1.45M | Buy |
|
|||||
|
2022
Q3 | $206K | Sell |
|
|||||
|
2022
Q2 | $303K | Buy |
|
|||||
|
2022
Q1 | $307K | Buy |
|
|||||
|
2021
Q4 | $276K | Sell |
|
|||||
|
2021
Q3 | $314K | Buy |
|
|||||
|
2021
Q2 | $233K | Buy |
|